title: Esorubicin in advanced ovarian epithelial cancer. A phase II study of the EORTC Gynecological Cancer Cooperative Group.
authors.affiliation: Department of Clinical Oncology, University Hospital, Leiden, The Netherlands.
authors.forename: A T
authors.initials: AT
authors.lastname: van Oosterom
authors.forename: M S
authors.initials: MS
authors.lastname: Aapro
authors.forename: F
authors.initials: F
authors.lastname: Carnino
authors.forename: M E
authors.initials: ME
authors.lastname: van der Burg
authors.forename: S
authors.initials: S
authors.lastname: Pecorelli
authors.forename: N
authors.initials: N
authors.lastname: Rotmensz
authors.forename: O
authors.initials: O
authors.lastname: Dalesio
authors.forename: J B
authors.initials: JB
authors.lastname: Vermorken
mesh_terms: D000328:Adult; D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D004317:Doxorubicin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy*
chemical_list: D000903:Antibiotics, Antineoplastic; D004317:Doxorubicin; C030851:esorubicin